Patient Perspectives in Squamous Cell Carcinoma Clinical Trials

Clinical research participation has historically been heavily biased toward specific demographics.

This study will invite several participants to gather a wide range of information on clinical trial experiences for squamous cell carcinoma patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of squamous cell carcinoma.

People with squamous cell carcinoma who are invited to take part in clinical research will benefit from the analysis of the data.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Squamous Cell Carcinoma Carcinoma Carcinoma, Squamous Cell Neoplasms Neoplasms by Histologic Type Neoplasms, Glandular and Epithelial Neoplasms, Squamous Cell

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Power Life Sciences

San Francisco, California, 94107, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Aged ≥ 18 years old
Confirmed diagnosis of squamous cell carcinoma
Subjects willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examination.

Exclusion criteria

Inability to provide written informed consent
Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study
Enrolled in another research study

Treatment and study plan

Primary outcomes

Number of patients who decide to enroll in a squamous cell carcinoma clinical trial

Time frame: 3 months
Rate of patients who remain in squamous cell carcinoma clinical trial to trial completion

Time frame: 12 months

Study contacts

Contact information is provided by the study sponsor or research team.

Michael B Gill

CONTACT

[email protected]

(415) 900-4227

Sponsors and collaborators

Lead sponsor

Power Life Sciences Inc.

Industry

Registry information

Official study title

An In Depth Study Examining Patterns in the Clinical Trial Experiences of Squamous Cell Carcinoma Patients

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2026
First posted: Jul 3, 2023
Registry last updated: Jul 3, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting